The government and ABPI agree to accelerate a planned review of VPAG
A planned autumn review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG) will be brought forward to report back in June.
Read the full articleYou might also wanna read
Study to Assess Effectiveness of Oral Atogepant in Adult Participants For Prevention of Migraine in the United Kingdom
Conditions : Migraine Sponsors : AbbVie Not yet recruiting
Virtual & Digital Health Digest
This digest covers key virtual and digital health regulatory and public policy developments during May and early June 2026 from the United S
NHS Fast-tracks Life-changing Medicines in Landmark UK-US Access Overhaul
A new series of NHS pilot schemes could give patients access to innovative medicines months earlier while supporting investment in the UK's
EMA 2025 annual report: 104 human medicines recommended for marketing authorisation
Report highlights progress in science, medicines and health in 2025
ema.europa.eu·29d ago
UK Government Adjusts Closure Timeline for Gigabit Broadband Voucher Scheme
The Government’s Building Digital UK (BDUK) agency has tweaked the closure plan for their Gigabit Broadband Voucher Scheme (GBVS), which giv
ispreview.co.uk·1mo agoVirtual and Digital Health Digest
This digest covers key virtual and digital health regulatory and public policy developments during February and early March 2026 from the Un
Comments
Sign in to join the conversation.
No comments yet. Be the first.